Capital International Investors’s CRISPR Therapeutics CRSP Stock Holding History

Capital International Investors’s Portfolio CRSP Stock Details CRSP Fund Activity

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$272M	Sell	5,593,747 -479,371	-8%	-$23.3M	0.05%	205
2025 Q1	$207M	Sell	6,073,118 -2,670,405	-31%	-$90.9M	0.04%	218
2024 Q4	$344M	Buy	8,743,523 +816,789	+10%	+$32.1M	0.06%	188
2024 Q3	$372M	Buy	7,926,734 +61,481	+0.8%	+$2.89M	0.07%	182
2024 Q2	$425M	Buy	7,865,253 +28,179	+0.4%	+$1.52M	0.09%	169
2024 Q1	$534M	Buy	7,837,074 +1,702,624	+28%	+$116M	0.11%	158
2023 Q4	$384M	Buy	6,134,450 +48,938	+0.8%	+$3.06M	0.09%	178
2023 Q3	$276M	Buy	6,085,512 +15,789	+0.3%	+$717K	0.07%	197
2023 Q2	$341M	Buy	6,069,723 +46,085	+0.8%	+$2.59M	0.08%	190
2023 Q1	$272M	Buy	6,023,638 +669,088	+12%	+$30.3M	0.07%	211
2022 Q4	$218M	Buy	5,354,550 +12,132	+0.2%	+$493K	0.06%	229
2022 Q3	$349M	Buy	5,342,418 +678,464	+15%	+$44.3M	0.1%	185
2022 Q2	$283M	Buy	4,663,954 +1,061,802	+29%	+$64.5M	0.08%	211
2022 Q1	$226M	Buy	3,602,152 +10,992	+0.3%	+$690K	0.05%	249
2021 Q4	$272M	Sell	3,591,160 -586,507	-14%	-$44.4M	0.06%	237
2021 Q3	$468M	Sell	4,177,667 -413,254	-9%	-$46.3M	0.11%	180
2021 Q2	$743M	Sell	4,590,921 -277,768	-6%	-$45M	0.17%	131
2021 Q1	$593M	Sell	4,868,689 -2,558,027	-34%	-$312M	0.15%	147
2020 Q4	$1.14B	Buy	7,426,716 +32,442	+0.4%	+$4.97M	0.31%	91
2020 Q3	$618M	Buy	7,394,274 +6,841,159	+1,237%	+$572M	0.19%	124
2020 Q2	$40.6M	Hold	553,115	–	–	0.01%	318
2020 Q1	$23.5M	Buy	553,115 +178,115	+47%	+$7.55M	0.01%	310
2019 Q4	$22.8M	Buy	375,000 +237,000	+172%	+$14.4M	0.01%	306
2019 Q3	$5.66M	Hold	138,000	–	–	﹤0.01%	375
2019 Q2	$6.5M	Hold	138,000	–	–	﹤0.01%	373
2019 Q1	$4.93M	Hold	138,000	–	–	﹤0.01%	369
2018 Q4	$3.94M	Hold	138,000	–	–	﹤0.01%	364
2018 Q3	$6.12M	Buy	+138,000	New	+$6.12M	﹤0.01%	360